Literature DB >> 2848417

Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.

R C Goldszer1, L S Lilly, H S Solomon.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2848417     DOI： 10.1016/s0002-9343(88)80047-0

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring.

Authors:  K Kubota; N Kubota; G L Pearce; W H Inman
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 2.  Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.

Authors:  F Deget; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

Review 3.  ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.

Authors:  A Overlack
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

4.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.

Authors:  K S Woo; M G Nicholls
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

5.  Cough requiring discontinuance of angiotensin-converting enzyme inhibitors in an urban inner-city population.

Authors:  J Freeman
Journal:  J Natl Med Assoc       Date:  1992-12       Impact factor: 1.798
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.